NOTICIAS
FDA final guidance on obtaining informed consent in drug and device clinical trials
This guidance is intended to assist institutional review boards (IRBs), clinical investigators, and sponsors in complying with FDA’s informed consent regulations for clinical investigations. This guidance supersedes FDA’s guidance entitled “A Guide to Informed...
Draft Guidance for Industry: Registration and Listing of Cosmetic Product Facilities and Products
This guidance provides recommendations and instructions to assist persons submitting cosmetic product facility registrations and product listings to FDA. This guidance document explains, among other things: The statutory requirement to submit cosmetic product...
TEAM-NB Position Paper on New MDR Transition Timelines and Notified Body Capacity
The medical device Regulation (EU) 2017/745 (MDR) came into force in 2017 to supersede the MDD (Medical Device Directive) and AIMDD (Active Implantable Medical Device Directive). The development of this new regulation was focused on addressing perceived...
EU Commission Updates Labelling Rules for Fragrance Allergens in Cosmetics
Commission Regulation (EU) 2023/1545 of 26 July 2023 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards labelling of fragrance allergens in cosmetic products THE EUROPEAN COMMISSION, Having regard to the Treaty on the...
Reflection paper on the use of artificial intelligence in the lifecycle of medicines
EMA News EMA has published a draft reflection paper outlining the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of human and veterinary medicines. This paper, which is now open for public...
The state of AI in 2023: Generative AI’s breakout year
Published by McKinsey Insights The latest annual McKinsey Global Survey on the current state of AI confirms the explosive growth of generative AI (gen AI) tools. Less than a year after many of these tools debuted, one-third of our survey respondents say their...
Innovation in Data-Driven Health Care
Harvard Business Publishing: https://hbr.org/sponsored/2023/08/innovation-in-data-driven-health-care Innovative uses of data in health care are helping solve the most challenging problems in patient health and operational efficiency. Today, many health care...
Technical document : Principles and Practices for the Cybersecurity of Legacy Medical Devices
This document is designed to provide concrete recommendations on how to apply the TPLC to legacy devices to aid in the implementation of the framework put forward in the preceding IMDRF N60 guidance. This document is complementary to the IMDRF N60 guidance, and the...
Updated document – Notified Bodies Survey on certifications and applications (MDR/IVDR) (Survey results with data status 31 March 2023)
DOWNLOAD PDF Notified Bodies Survey on certifications and applications (MDR/IVDR
Revisão das Boas Práticas Regulamentares
25 JULHO 2023. ORDEM DOS FARMACÊUTICOS O Conselho do Colégio de Especialidade de Assuntos Regulamentares da Ordem dos Farmacêuticos (CCEAR-OF) atualizou o guia de Boas Práticas Regulamentares, cuja primeira edição foi publicada em março de 2004. Excetuando o capítulo...
GUIDANCE DOCUMENT Qualification of Medical Device Development Tools
This guidance describes a voluntary program for the qualification of medical device development tools (MDDTs) for use in the evaluation of devices regulated by CDRH. Specifically, this guidance describes the framework for voluntary proposal and qualification of an...
CEP 2.0: implementation date
The European Directorate for the Quality of Medicines & HealthCare (EDQM) is pleased to announce that the CEP 2.0 will be implemented on 1 September 2023. From that date onwards, new dossier applications and renewal applications will receive a CEP 2.0, whereas...
Reflection paper on the use of artificial intelligence in the lifecycle of medicines
EMA has published a draft reflection paper outlining the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of human and veterinary medicines. This paper, which is now open for public...
EXTENSION OF THE MDR TRANSITIONAL PERIOD AND REMOVAL OF THE ‘SELL OFF’ PERIODS. july 2023
Q&A on practical aspects related to the implementation of Regulation (EU) 2023/607 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices Introduction –...
Projeto Piloto eFI (folheto informativo em formato eletrónico): 1ª fase medicamentos de uso exclusivo hospitalar
O INFARMED, I.P. pretende iniciar o projeto piloto eFI (Folheto Informativo em formato eletrónico), que consiste na retirada dos folhetos informativos em papel das embalagens de medicamentos destinadas a ser comercializadas apenas no circuito hospitalar e para...
EUROPEAN COMMISSION European Innovation Scoreboard 2023.
Bold policies and increased investments in Research & Development are necessary to contribute to the success of Europe’s digital and green agenda. This can help enhance resilience and technological sovereignty, and strengthen the competitiveness of our single...
Artificial intelligence act
Briefing 28-06-2023 The European Commission tabled a proposal for an EU regulatory framework on artificial intelligence (AI) in April 2021. The draft AI act is the first ever attempt to enact a horizontal regulation for AI. The proposed legal framework focuses on the...
2023 emerging technologies and scientific innovations: a global public health perspective
Overview This publication presents the findings of a global horizon scan of innovations in science and technology that could help solve global health challenges. An expert group scored over 100 innovations for their potential impact and the chance of wide...
COMMISSION IMPLEMENTING DECISION (EU) 2023/1410 amending Implementing Decision (EU) 2021/1182 as regards harmonised standards for sterilization of health care products and biological evaluation of medical devices
THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 1025/2012 of the European Parliament and of the Council of 25 October 2012 on European standardisation, amending Council Directives...
EU HEALTH COALITION Manifesto for a Healthier Europe
On the heels of the most severe pandemic in decades, European healthcare systems are facing a perfect storm of ageing populations, growing prevalence of chronic diseases, significant health workforce shortages, and the unfolding energy, climate, cost of living, and...
Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol
Scope of the Guideline To outline the practical arrangements for notification of serious breaches; this document does not cover notifications related to unexpected events, other reporting obligations related to the safety of trial participants or urgent safety...
REGULATORY ROAD TO INNOVATION: DELIVERING A WORLD CLASS 21ST CENTURY REGULATORY FRAMEWORK
As part of the EU Pharmaceuticals Strategy, and lessons learned from the COVID-19 pandemic, the European Commission (EC) declared its plans to assess and revise the EU’s general legislation on medicines for human use (Directive 1001/83/EC and Regulation 776/2004) to...
MDCG Position Paper on the application of Article 97 MDR to legacy devices for which the MDD or AIMDD certificate expires before the issuance of a MDR certificate
This document has been endorsed by the Medical Device Coordination Group (MDCG) established by Article 103 of Regulation (EU) 2017/745. The MDCG is composed of representatives of all Member States and it is chaired by a representative of the European Commission. The...
AUTOINSPEÇÕES / AUDITORIA INTERNA ao Sistema GDP: Mais uma edição marcada pelo sucesso
“Excelente formação , apresentada com muita clareza e casos práticos que serão muito úteis no dia a dia . Espaço para questões e esclarecimento de dúvidas. Muita empatia, conhecimentos e disponibilidade da formadora. “ GILEAD Mais uma edição da formação...
The economic potential of generative AI : Pharmaceuticals and medical products
Generative AI deployment could unlock potential value equal to 2.6 to 4.5 percent of annual revenues across the pharmaceutical and medical-product industries Our analysis finds that generative AI could have a significant impact on the pharmaceutical and...
Use of real-world evidence in regulatory decision making – EMA publishes review of its studies
News 23/06/2023 Real-world evidence (RWE) from studies led by regulators can complement evidence from other sources including clinical trials. RWE can support both pre-authorisation and post-approval assessments of EMA’s scientific committees, working parties...
Scaling Smart Solutions with AI in Health: Unlocking Impact on High potential use cases
The healthcare sector is grappling with critical challenges, such as a shortage of frontline workers, health disparities and escalating spending. Artificial intelligence (AI) promises transformative potential to tackle these issues. The healthcare sector is...
ANVISA : Manual de Importação de Dispositivos Médicos
O manual tem o objetivo de orientar os importadores sobre as regras para submissão e os procedimentos de análise de processos de importação de dispositivos médicos sob responsabilidade do Posto de Anuência de Importação de Produtos para Saúde (PAFPS). Os...
REGULATORY MEDICAL WRITING: ” Formação útil , com excelentes exemplos “
Decorreu no dia 23 de junho a sessão formativa :REGULATORY MEDICAL WRITING, bajo o lema "Técnicas base e boas práticas da escrita médica para criar documentos precisos, submission-ready, e com uma mensagem eficaz" ; um Workshop Prático para aperfeiçoar as ...
VALIDAÇÃO de MÉTODOS ANALÍTICOS : “Tema complexo muito bem abordado “
Teve lugar no dia 22 de junho o workshop prático : VALIDAÇÃO de MÉTODOS ANALÍTICOS conduzido pela reconhecida especialista Dra Sandra Almeida, Responsável de Controlo de Qualidade, da CANNAPAC Este workshop teve como objetivo oferecer um conhecimento...
ICH has announced plans to work on three new topics this year covering patient preference studies, non-clinical safety studies for oligonucleotide-based therapeutics and bioequivalence studies for modified release products.
Press Release: ICH Assembly Meeting, Vancouver, Canada, June 2023 20 June 2023 New Areas of Harmonisation Adopted, Alongside Significant Advancement of Ongoing Activities The Assembly of the International Council for Harmonisation (ICH) met in-person on 12 & 13...
FDA Investigations Operations Manual 2023
The Investigations Operations Manual (IOM) is the primary operational reference for FDA employees who perform field activities in support of the agency’s public health mission. Accordingly, it directs the conduct of all fundamental field activities. Adherence to this...
HEALTH ADVANCES – DIGITAL THERAPEUTIC ALLIANCE GUIDANCE TO INDUSTRY: Classification of Digital Health Technologies
PUBLISHED BY healthadvances.com HEALTH ADVANCES - DIGITAL THERAPEUTIC ALLIANCE GUIDANCE TO INDUSTRY: Classification of Digital Health Technologies June 2023 PREFACE: PROJECT CONTEXT, OVERVIEW, AND METHODOLOGY The digital transformation of healthcare is in...
EUDAMED user guide Notified Bodies & Certificates . June 2023
The purpose of this user guide is to help you navigate through the Notified Bodies and Certificates process of registering certificates module in into EUDAMED.1 In order to successfully register a certificate in EUDAMED, this guide illustrates two scenarios including...
Cybersecurity and privacy in AI – Medical imaging diagnosis
This report allows better assessment of the reality that artificial intelligence brings its own set of threats, which consequently insists on the search for new security measures to counter them. Finally, it should be noted that this guide strongly emphasises privacy...
Content of Premarket Submissions for Device Software Functions
This guidance document is intended to provide information regarding the recommended documentation for premarket submissions for FDA’s evaluation of the safety and effectiveness of device software functions, which are software functions that meet the definition of a...
FDA Releases Two Discussion Papers to Spur Conversation about Artificial Intelligence and Machine Learning in Drug Development and Manufacturing
Artificial intelligence (AI) and machine learning (ML) are no longer futuristic concepts; they are now part of how we live and work. The U.S. Food and Drug Administration uses the term AI to describe a branch of computer science, statistics, and engineering that uses...
EUDAMED user guide UDI Devices Production v 2.11 . June 2023
Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnosis medical devices introduce an EU identification system for medical devices based on a Unique Device Identifier (UDI). The UDI-DI/Device module of EUDAMED is used for the...
Global Unique Device Identification Database (GUDID)
The Global Unique Device Identification Database (GUDID) is a database administered by the FDA that serves as a reference catalog for every device with a unique device identifier (UDI). GUDID contains ONLY the device identifier (DI) portion of the UDI, which serves as...
Boas práticas para a prevenção de ruturas de abastecimento
05 jun 2023 Circular Informativa n.º 052/CD/100.20.200 de 02/06/2023 A rede HMA1 e EMA2 publicaram recomendações para a indústria contendo boas práticas para assegurar a continuidade do abastecimento de medicamentos, prevenir ruturas e reduzir o seu impacto na saúde...
AUDITORIA A DOSSIERS DE AIM : “Um evento dinâmico, descontraído , muito proveitoso “
Recohecendo a alta prevalência de “inconformidades nos dossiers de AIM” nos diferentes procedimentos quando são submetidos,.a Formiventos organizou uma nova edição da formação sobre este tema : AUDITORIA A DOSSIERS DE AIM Foi uma sessão muito enriquecedora,...
BOAS PRÁTICAS de FARMACOVIGILÂNCIA: ” Formação precisa, focada e muito esclarecedora “
Decorreu nos passados 30 e 31 de maio uma nova edição do Seminário de actualização nas BOAS PRÁTICAS de FARMACOVIGILÂNCIA com o objetivo de lhe oferecer uma abordagem específica dos aspetos mais críticos e actuais relacionados com a gestão da qualidade, riscos,...
Progress with EU-US mutual recognition agreement for inspections for veterinary medicines
Published by EMA News 31/05/2023 Today, the European Union (EU) and the United States (US) have made important progress towards enabling mutual recognition of inspections of manufacturing facilities of certain veterinary products. The Food and Drug...
FDA Proposes New, Easy-to-Read Medication Guide for Patients, Patient Medication Information
Providing people with accurate and timely information to help them take their prescription medications safely and effectively is an important priority for the U.S. Food and Drug Administration. Evidence suggests that more easy-to-read information can help patients...
FDA final guidance clarifies whole slide imaging expectations in nonclinical toxicology studies
This guidance provides information to sponsors and nonclinical laboratories regarding the use and management of whole slide images used during histopathology assessment and/or pathology peer review performed for good laboratory practice (GLP)-compliant nonclinical...
MASTER COURSE SUPLEMENTOS ALIMENTARES: ” Formação extremamente esclarecedora e relevante. “
No passado 30 de maio teve lugar em Lisboa mais uma edição dp MASTER COURSE Autorização, publicidade e comercialização de SUPLEMENTOS ALIMENTARES bajo o lema " Uma visão global dos conhecimentos imprescindíveis para fabricar, introduzir e manter-se no Mercado de...
MedTech Europe’s vision for cybersecurity in the medical technology ecosystem – position paper
The digital ecosystem has dramatically changed the way in which healthcare is delivered to patients. Nowadays, medical technology companies concentrate not only on ensuring the safety and security of MDs and IVDs, but also on the protection of patients’ and users’...
Parecer 123/CNECV/2023 sobre o uso off-label de medicamentos – Implicações Éticas
O Conselho Nacional de Ética para as Ciências da Vida (CNECV) analisou as implicações éticas suscitadas pelo uso off-label de medicamentos, uma prática frequente na terapêutica nos diferentes sistemas de saúde, sublinhando que existe atualmente em Portugal uma...
Validação de Limpeza : “Formação adequada, acessível, com conhecimentos técnicos e casos práticos
No dia 23 de maio de 2023 teve lugar em Lisboa, uma nova edição da formação sobre Validação de Limpeza, bajo o lema : Técnicas para desenhar a sua estratégia de validação que garanta os melhores resultados em termos de produtividade , segurança, ergonomia e proteção...
IPEC Significant Change Guide for Pharmaceutical Excipients
The International Pharmaceutical Excipients Council Federation, (IPEC Federation) announces the availability of the updated IPEC Significant Change Guide for Pharmaceutical Excipients (Version 5, 2023). The guide was originally published in 2000 as an IPEC-Americas...
BPD NIVEL AVANÇADO : Uma viagem pelos 10 capítulos das GDP com relevância para os pontos mais críticos e pontuada com vários casos práticos
Teve lugar uma nova edição da formação exclusiva da Formiventos, sobre GDP Nível 2 : BOAS PRÁTICAS DE DISTRIBUIÇÃO Nível Avançado; uma sessão para profissionais com experiência consolidada em ambiente GDP, que pretendem uma formação de refreshing nas Boas Práticas...